Drug Information

Drug General Information
Drug ID
D0ZL0Z
Former ID
DNC012326
Drug Name
PT-304
Drug Type
Small molecular drug
Indication Discovery agent Phase 3 [522839]
Formula
C12H12FN3S2
Canonical SMILES
C1=CC(=C(C=C1CC2=NC3=C(N=C2CC4=CC(=C(C=C4)Cl)Cl)N=C(N=C<br />3N)N)Cl)Cl
InChI
1S/C20H14Cl4N6/c21-11-3-1-9(5-13(11)23)7-15-16(8-10-2-4-12(22)14(24)6-10)28-19-17(27-15)18(25)29-20(26)30-19/h1-6H,7-8H2,(H4,25,26,28,29,30)
InChIKey
BQHNVQLDZHGCDH-UHFFFAOYSA-N
PubChem Compound ID
3001163
Target and Pathway
Target(s) HIV-1 reverse transcriptase Target Info Inhibitor [534066]
References
Ref 522839ClinicalTrials.gov (NCT01007890) Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer. U.S. National Institutes of Health.
Ref 534066J Med Chem. 1995 Dec 8;38(25):4929-36.Phenethylthiazolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and basic structure-activity relationship studiesof PETT analogs.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.